Drug Approval | September 29, 2024
Briefs: Lupin, Alembic Pharmaceuticals and Piramal Pharma
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The company will also share results in two additional posters for deuruxolitinib
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Subscribe To Our Newsletter & Stay Updated
